Dr Lim Sue Zann
MBBS (Hons), M Med (Surgery), FRCS (Edin)
Languages: English, Mandarin, Bahasa Melayu
Dr Lim Sue Zann is a senior consultant practicing at Solis. She has a special interest in oncoplastic and minimally invasive breast surgery. Prior to joining Solis, she was a senior consultant at the SingHealth Duke-NUS Breast Centre, Singapore General Hospital and National Cancer Centre Singapore. She is highly experienced in the full spectrum of breast surgery, including breast-conserving surgery, minimally invasive mastectomy, partial breast reconstruction and reduction mammoplasty. With a passion for both clinical care and medical education, Dr Lim is actively involved in training the next generation of surgeons, while continuing to contribute to international research in breast cancer.
Training and Qualifications
Dr Lim graduated with honours from the University of Malaya in 2008 and subsequently earned her Master of Medicine in Surgery from the National University of Singapore. She became a Fellow of the Royal College of Surgeons of Edinburgh in 2017.
She completed the Advanced Breast Surgery Fellowship at Singapore General Hospital, where she was trained in both oncological and reconstructive surgical techniques. Her pursuit of surgical excellence took her to South Korea’s Asan Medical Center for training in minimally invasive breast surgery in 2022, and subsequently to the Royal Marsden Hospital, London in 2023 to learn advanced oncoplastic techniques.
Accolades and Achievements
An advocate for surgical education, Dr Lim plays a key role in residency and junior doctor training programmes. As Associate Programme Director of the General Surgery Residency, she has been pivotal in curriculum development and mentorship initiatives. Her dedication to teaching was recognized with the Dean’s Award for Teaching Excellence from the Yong Loo Lin School of Medicine in 2013.
Dr Lim’s research interests mainly focused on the de-escalation of axillary surgery, breast sarcomas, phyllodes tumours, and broadening access to breast-conserving surgical options. She has authored over 15 peer-reviewed publications and presented her work at numerous international breast cancer conferences. Notably, she served as Principal Investigator on a Singapore General Hospital-funded study examining prognostic factors and outcomes in breast sarcomas and phyllodes tumours.
Dr Lim also contributes actively to institutional leadership through her involvement in hospital committees such as the Elective Surgery Task Force and the Operating Theatre Management Committee, shaping patient-centric surgical care policies.
In recognition of her service and clinical excellence, she has received numerous awards, including the Singapore Health Quality Service Gold Award (2025), the Singapore General Hospital Service with a Heart Award (2024, 2015), the SingHealth Best Registrar Award (2016), and multiple undergraduate medals and prizes from the University of Malaya (2008).
Read Articles By Dr Lim Sue Zann
Case report of an internal hernia through a unilateral congenital defect of the broad ligament and literature review.
Lim SZ, Tan VKM, Teo MCC.
Proceedings of Singapore Healthcare. 2012; 21(3): 213-6
Sarcoma of the breast: an update on a rare entity.
Lim SZ, Ong KW, Tan BK, Selvarajan S, Tan PH.
J Clin Pathol. 2016 May;69(5):373-81.
Doi: 10.1136/jclinpath-2015-203545.
Breast sarcomas and malignant phyllodes tumours: comparison of clinicopathological features, treatment strategies, prognostic factors and outcomes.
Lim SZ, Selvarajan S, Thike AA, Nasir ND, Tan BK, Ong KW, Tan PH.
Breast Cancer Res Treat. 2016 Sep;159(2):229-44.
Doi: 10.1007/s10549-016-3946-1.
Genomic profile of breast sarcomas: a comparison with malignant phyllodes tumours.
Lim SZ, Ng CCY, Rajasegaran V, Guan P, Selvarajan S, Thike AA, Nasir NDBM, Koh VCY, Tan BKT, Ong KW, Teh BT, Tan PH.
Breast Cancer Res Treat. 2019 Apr;174(2):365-373.
Doi: 10.1007/s10549-018-5067-5.
A Circulating miRNA Signature for Stratification of Breast Lesions among Women with Abnormal Screening Mammograms.
Loke SY, Munusamy P, Koh GL, Chan CHT, Madhukumar P, Thung JL, Tan KTB, Ong KW, Yong WS, Sim Y, Oey CL, Lim SZ, Chan MYP, Ho TSJ, Khoo BKJ, Wong SLJ, Thng CH, Chong BK, Tan EY, Tan VK, Lee ASG.
Cancers (Basel). 2019 Nov 26;11(12):1872.
Doi: 10.3390/cancers11121872.
A pilot study comparing Sentimag/Sienna versus standard modality for sentinel lymph node identification in patients with breast cancer.
Hamzah JL, Tan BKT, Tan V, Madhukumar P, Lim SZ, Sim YR, Yong WS, Lee ZJ, Ong KW.
Breast J. 2020 May;26(5):1074-1077.
Doi: 10.1111/tbj.13660.
Impact of hormonal status on ductal carcinoma in situ of the breast: Outcome and prognostic factors.
Tay THC, Ng WY, Ong KW, Wong CY, Tan BKT, Yong WS, Madhukumar P, Tan VKM, Lim SZ, Sim Y.
Breast J. 2020 May;26(5):937-945.
Doi: 10.1111/tbj.13738.
Shaping of the abdominal flap in breast reconstruction: The coning technique in muscle sparing TRAM.
Rutherford CL, Tan BK, Lim SZ, Chew KY.
JPRAS Open. 2020 Jul 31;25:93-98.
Doi: 10.1016/j.jpra.2020.07.003. Erratum in: JPRAS Open. 2021 Sep 24;30:180-181.
Outcomes of Stage I and II Breast Cancer with Nodal Micrometastases Treated with Mastectomy without Axillary Therapy.
Lim SZ, Kusumawidjaja G, Mohd Ishak HM, Tan BKT, Tan SY, Hamzah JL, Madhukumar P, Yong WS, Wong CY, Sim Y, Lim GH, Lim SH, Tan SM, Wong FY, Tan VKM.
Breast Cancer Res Treat. 2021 Oct;189(3):837-843.
Doi: 10.1007/s10549-021-06341-1.
Development of a microRNA Panel for Classification of Abnormal Mammograms for Breast Cancer.
Zou R, Loke SY, Tan VK, Quek ST, Jagmohan P, Tang YC, Madhukumar P, Tan BK, Yong WS, Sim Y, Lim SZ, Png E, Lee SYS, Chan MYP, Ho TSJ, Khoo BKJ, Wong SLJ, Thng CH, Chong BK, Teo YY, Too HP, Hartman M, Tan NC, Tan EY, Lee SC, Zhou L, Lee ASG.
Cancers (Basel). 2021 Apr 28;13(9):2130.
Doi: 10.3390/cancers13092130.
Bone in the breast: Clinical, radiological and pathological correlation.
Lim CHS, Leong LCH, Lim SZ, Su MN, Moey THL, Tay KYT, Tan PH.
Ann Acad Med Singap. 2021 Oct;50(10):798-801.
Doi: 10.47102/annals-acadmedsg.2020611. PMID: 34755177.
Atypical Ductal Hyperplasia of the Breast on Core Needle Biopsy: Risk of Malignant Upgrade on Surgical Excision.
Bong TSH, Tan JKT, Ho JTS, Tan PH, Lau WS, Tan TM, Wong JSL, Tan VKM, Tan BKT, Madhukumar P, Yong WS, Lim SZ, Wong CY, Ong KW, Sim Y.
J Breast Cancer. 2022 Feb;25(1):37-48.
Doi: 10.4048/jbc.2022.25.e7.
The Impact of Statin Use and Breast Cancer Recurrence – A Retrospective Study in Singapore.
Sim Y, Lim C, Phyu N, Tan KTB, Chew LST, Wong CY, Madhukumar P, Yong WS, Lim SZ, Hamzah JLB, Tan SY, Chay WY, Wong FY, Tan PH, Tan VK.
Front Oncol. 2022 Mar 31;12:835320.
Doi: 10.3389/fonc.2022.835320.
Male breast cancer: a Singapore perspective.
Lim JSH, Sim Y, Ngeow J, Yuen J, Tan VKM, Tan BKT, Yong WS, Wong CY, Lim SZ, Hamzah JLB, Tan SY, Wong FY, Madhukumar P.
ANZ J Surg. 2022 Jun;92(6):1440-1446.
Doi: 10.1111/ans.17737.
Long-term outcome in patients with nodal-positive breast cancer treated with sentinel lymph node biopsy alone after neoadjuvant chemotherapy.
Lim SZ, Yoo TK, Lee SB, Kim J, Chung IY, Ko BS, Lee JW, Son BH, Ahn SH, Kim S, Kim HJ.
Breast Cancer Res Treat. 2024 Jan;203(1):95-102.
Doi: 10.1007/s10549-023-07104-w. Epub 2023 Oct 5. PMID: 37796365.